Another Post-Trump Trade: Revisiting Sun Pharmaceuticals (SUNP IN) After Q2 (FY2017) Earnings

264 Views13 Nov 2016 04:17

We initiated coverage on Sun Pharmaceutical Indus (SUNP IN) with Buy rating and common stock price target of INR 855 earlier this month. Link to...

SUMMARY

(Sign Up to Access)

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Full Insight

(Paid Plans Only, 2-minute read)

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream